Sugimoto et al., 2008 - Google Patents
Acute interstitial nephritis associated with etanerceptSugimoto et al., 2008
- Document ID
- 1601116159721586972
- Author
- Sugimoto T
- Yasuda M
- Sakaguchi M
- Koyama T
- Uzu T
- Nishioka J
- Kashiwagi A
- Publication year
- Publication venue
- Rheumatology International
External Links
Snippet
Acute interstitial nephritis associated with etanercept Page 1 Rheumatol Int (2008) 28:1283–1284
DOI 10.1007/s00296-008-0609-5 123 SHORT COMMUNICATION Acute interstitial nephritis
associated with etanercept Toshiro Sugimoto · Mako Yasuda · Masayoshi Sakaguchi · Tetsuro …
- 108010008165 Etanercept 0 title abstract description 16
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dutra et al. | Autoimmune encephalitis: a review of diagnosis and treatment | |
| Tattevin et al. | Aseptic meningitis | |
| Pinheiro et al. | Pediatric lupus nephritis | |
| Cohen Aubart et al. | Histiocytosis and the nervous system: from diagnosis to targeted therapies | |
| Blincoe et al. | Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis | |
| Londoño Jimenez et al. | Brief report: tubulointerstitial damage in lupus nephritis: a comparison of the factors associated with tubulointerstitial inflammation and renal scarring | |
| Oelzner et al. | Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus–relationship with disease activity and renal involvement | |
| Mamlouk et al. | Checkpoint inhibitor-related renal vasculitis and use of rituximab | |
| Zhang et al. | C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis | |
| Qin et al. | Rheumatoid meningitis: a case report and review of the literature | |
| Brito-Zerón et al. | Treating the underlying pathophysiology of primary Sjögren syndrome: recent advances and future prospects | |
| Chevalier et al. | Renal prognosis in children with tubulointerstitial nephritis and uveitis syndrome | |
| Xie et al. | Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis | |
| Younger | Overview of the vasculitides | |
| Sugimoto et al. | Acute interstitial nephritis associated with etanercept | |
| Pontarini et al. | Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets | |
| Fanni et al. | Congenital nephrotic syndrome | |
| Qorban et al. | Rheumatoid arthritis, pathophysiology and management | |
| Sakai et al. | Corticosteroid-and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab | |
| US12030950B2 (en) | Treatment of multiple sclerosis and neuromyelitis optica | |
| Murakami et al. | Three-year follow-up of rheumatoid meningitis with matrix metalloprotease-9 levels in the serum and cerebrospinal fluid as indicators of disease activity: A case report | |
| Hoffmann et al. | Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies | |
| Origuchi et al. | Immunoglobulin G4-related disease with marked eosinophilia: a case report and literature review | |
| Kamal et al. | Upregulation of necroptosis markers RIPK3/MLKL and their crosstalk with autophagy-related protein Beclin-1 in primary immune thrombocytopenia | |
| Kawato et al. | Development of a novel Poly (I: C)-induced murine model with accelerated lupus nephritis and examination of the therapeutic effects of mycophenolate mofetil and a cathepsin S inhibitor |